查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600798

表观遗传学市场：按产品、技术、工艺、应用和最终用户分类 - 全球预测 2025-2030

Epigenetics Market by Product, Technique, Methods, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年表观遗传学市场价值为37.1亿美元，预计到2024年将达到41亿美元，复合年增长率为10.82%，到2030年将达到76.3亿美元。

表观遗传学是一个快速发展的领域，涉及基因功能的遗传变化的研究，不涉及DNA序列的变化，以了解复杂的生物过程，例如发育、疾病表达和对环境因素的反应，在上述过程中发挥着重要作用。表观遗传学的需求在于阐明癌症、神经系统疾病和自体免疫疾病等各种疾病的潜在机制，从而实现标靶治疗方法和个人化医疗。其应用范围广泛，包括药物发现、生物标记物开发、农业和环境研究，最终用途主要在医疗保健、製药和生物技术行业。市场成长是由次世代定序和 CRISPR 等技术进步、慢性病盛行率增加以及研发投资增加所推动的。然而，与表观表观基因研究相关的高成本、伦理问题和资料解释的复杂性构成了重大挑战。为了利用潜在的机会，相关人员应专注于降低定序成本和增强资料分析工具。学术机构和行业相关人员之间的合作可以促进新表观遗传标靶的识别和相应治疗方法的开发方面的创新。虽然北美和欧洲等地区目前凭藉成熟的医疗保健系统引领市场，但亚太地区的新兴市场由于基础设施的改善和医疗保健支出的增加而提供了利润丰厚的机会。监管障碍和有限的报销框架等限制可能会阻碍市场的快速扩张。在改进诊断工具、开发表观遗传生物标记以及可以修改表观遗传标记的新治疗方法还有创新的空间。为了保持竞争力，公司应该专注于策略伙伴关係、客製化产品以及利用人工智慧进行资料分析。总体而言，表观遗传学市场的动态性质需要灵活的策略和持续的创新来克服挑战并利用巨大的成长潜力。

主要市场统计
基准年[2023] 37.1亿美元
预测年份 [2024] 41亿美元
预测年份 [2030] 76.3亿美元
复合年增长率（%） 10.82%

市场动态：揭示快速发展的表观遗传学市场的关键市场洞察

表观遗传学市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球慢性病和遗传疾病的盛行率显着增加
    • 政府在药物发现和开发方面的积极措施和投资
    • 对个人化医疗的偏好日益增加
  • 市场限制因素
    • 开发表观遗传学技术成本高昂
  • 市场机会
    • 持续进行研究和开发活动以推进表观遗传学
    • 将表观遗传学的应用扩展到非癌症领域
  • 市场挑战
    • 表观遗传学认识不足，应用范围狭窄

波特的五力策略工具驾驭表观遗传学市场

波特的五力框架是了解表观遗传学市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解表观遗传学市场的外部影响

外部宏观环境因素在塑造表观遗传学市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解表观遗传学市场的竞争格局

表观遗传学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵表观遗传学市场供应商绩效评估

FPNV定位矩阵是评估表观遗传学市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地慢性病和遗传疾病的盛行率正在显着增加。
      • 政府在药物发现和开发方面的有利措施和投资
      • 个性化医疗的成长趋势
    • 抑制因素
      • 表观遗传学技术开发成本高
    • 机会
      • 持续进行表观遗传学的研究与发展活动
      • 将表观遗传学的应用扩展到非肿瘤学领域
    • 任务
      • 表观遗传学缺乏认识且应用有限
  • 市场区隔分析
    • 产品：表观遗传学研究试剂和套件的使用增加
    • 技术：扩大次世代定序在全基因组甲基化分析的应用
    • 方法：增加 X 染色体惰性中 DNA 甲基化的利用率
    • 应用：增加表观遗传学工具在肿瘤学的应用
    • 最终用户：学术和研究机构对錶观遗传学工具的需求不断增长
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章表观遗传学市场：副产品

  • 酵素
    • DNA修饰酶
    • 蛋白质修饰酶
  • 乐器及配件
  • 试剂和套件
    • 5-hmC 和 5-mC 分析套件
    • 抗体
    • 亚硫酸氢盐转换套件
    • ChiP-seq套件
    • 组蛋白
    • 全基因组扩增试剂套件
  • 服务
  • 软体

第七章表观遗传学市场：依技术分类

  • 质谱分析
  • 次世代定序
  • 聚合酵素链锁反应与定量聚合酵素链锁反应
  • 超音波

第 8 章表观遗传学市场（依方法）

  • DNA甲基化
  • 组蛋白修饰

第九章表观遗传学市场：依应用分类

  • 心血管疾病
  • 发育生物学
  • 免疫学
  • 代谢性疾病
  • 肿瘤学

第 10 章表观遗传学市场：依最终使用者分类

  • 学术研究所
  • 合约调查机构
  • 製药和生物技术公司

第十一章美洲表观遗传学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太表观遗传学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的表观遗传学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Zenith 和 Sencora 合作加速 ZEN-3694 项目
    • FOXO 与 DataRobot 合作进行以人工智慧为基础的表观遗传生物标记研究
    • Zymo Investigations 和 Opentrons 合作实现新型无细胞 DNA 分离化学的自动化
    • MSU 生物化学家接受NIH 280 万美元津贴，用于研究泛自闭症障碍的表观遗传学
    • 安捷伦宣布收​​购用于癌症研究的高性能 NGS靶向序列捕获工作流程开发商 Avida Biomed
    • Astra Zeneca推进产品线，在 AACR 上强调免疫肿瘤学、ADC、细胞治疗和表观遗传学的进展
    • Biomodal 发布遗传学和表观遗传学解决方案
    • Chroma Medicine 专注于表观遗传编辑
    • 易卜生收购 Epizyme 以扩大肿瘤产品组合
    • Zenith Epi Genetics 宣布开始由美国国家癌症研究所 (NCI) 赞助的多项肿瘤学临床试验

公司名单

  • Diagenode SA by Hologic, Inc.
  • STORM Therapeutics LTD
  • Qiagen NV
  • Integrated DNA Technologies, Inc. by Danaher Corporation
  • Active Motif, Inc.
  • Merck KGaA
  • Novogene Co, Ltd.
  • GenomeScan
  • Thermo Fisher Scientific Inc.
  • Abnova Corporation
  • New England Biolabs, Inc.
  • Epigenic Therapeutics
  • Ipsen
  • Twist Bioscience Corporation
  • F. Hoffmann-La Roche Ltd.
  • AstraZeneca PLC
  • GenScript Biotech Corporation
  • Exact Sciences Corporation
  • FOXO Technologies Inc.
  • Watchmaker Genomics, Inc.
  • Chroma Medicine, Inc.
  • Cambridge Epigenetix Ltd.
  • Bristol-Myers Squibb Company
  • EpiCypher, Inc.
  • Omega Therapeutics, Inc.
  • Promega Corporation
  • Bioneer Corporation
  • PerkinElmer, Inc.
  • Gilead Sciences, Inc.
  • Eurofins Scientific SE
  • ProteoGenix SAS
  • Abcam PLC
  • BioCat GmbH by AddLife AB
  • Creative Diagnostics
  • EpiGentek Group Inc.
  • Lonza Group Ltd.
  • Zenith Epigenetics Ltd.
  • Agilent Technologies, Inc.
  • BPS Bioscience, Inc.
  • Fios Genomics Ltd.
  • Creative Biogene
  • Sound Agriculture Company
  • Takara Holdings Inc.
  • Illumina, Inc.
  • Elysium Health, Inc.
  • Pacific Biosciences of California, Inc
  • Cusabio Technology LLC
  • Zymo Research Corporation
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • MorphoSys AG
Product Code: MRR-0D217D5ADE3D

The Epigenetics Market was valued at USD 3.71 billion in 2023, expected to reach USD 4.10 billion in 2024, and is projected to grow at a CAGR of 10.82%, to USD 7.63 billion by 2030.

Epigenetics, a burgeoning field involving the study of heritable changes in gene function that do not involve alterations in the DNA sequence, plays a crucial role in understanding complex biological processes such as development, disease manifestation, and response to environmental factors. The necessity of epigenetics lies in its potential to unravel mechanisms underlying various diseases, including cancer, neurological disorders, and autoimmune diseases, thus enabling targeted therapeutic approaches and personalized medicine. Its applications span across drug discovery, biomarkers development, agriculture, and environmental studies, with end-use predominantly in healthcare, pharmaceutical, and biotech industries. Market growth is driven by advancements in technology such as next-generation sequencing and CRISPR, increasing prevalence of chronic diseases, and growing investment in R&D. However, high costs associated with epigenomic research, ethical concerns, and complexity in data interpretation pose significant challenges. To capitalize on potential opportunities, stakeholders should focus on reducing sequencing costs and enhancing data analysis tools. Collaborations between academic institutions and industry players could foster innovation in identifying novel epigenetic targets and developing corresponding therapies. Currently, regions like North America and Europe lead the market due to established healthcare systems, but emerging markets in Asia-Pacific present lucrative opportunities owing to improving infrastructure and increasing healthcare expenditure. Limitations such as regulatory hurdles and limited reimbursement frameworks may hinder rapid market expansion. The scope for innovation lies in improved diagnostic tools, development of epigenetic biomarkers, and novel therapies that can modify epigenetic marks. Businesses should focus on strategic partnerships, tailored product offerings, and leveraging artificial intelligence for data analysis to stay competitive. Overall, the dynamic nature of the epigenetics market demands agile strategies and sustained innovation to navigate the challenges and capitalize on the vast potential for growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.71 billion
Estimated Year [2024] USD 4.10 billion
Forecast Year [2030] USD 7.63 billion
CAGR (%) 10.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Epigenetics Market

The Epigenetics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant growth in the prevalence of chronic and genetic disorders worldwide
    • Favorable governmental initiatives and investments in drug discovery and development
    • Growing inclination toward personalized medicines
  • Market Restraints
    • High cost of development of epigenetics technologies
  • Market Opportunities
    • Ongoing research and development activities for the advancement of epigenetics
    • Expanding the application of epigenetics in non-oncology fields
  • Market Challenges
    • Lack of awareness and limited application of epigenetics

Porter's Five Forces: A Strategic Tool for Navigating the Epigenetics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Epigenetics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Epigenetics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Epigenetics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Epigenetics Market

A detailed market share analysis in the Epigenetics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Epigenetics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Epigenetics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Epigenetics Market, highlighting leading vendors and their innovative profiles. These include Diagenode S.A. by Hologic, Inc., STORM Therapeutics LTD, Qiagen N.V., Integrated DNA Technologies, Inc. by Danaher Corporation, Active Motif, Inc., Merck KGaA, Novogene Co, Ltd., GenomeScan, Thermo Fisher Scientific Inc., Abnova Corporation, New England Biolabs, Inc., Epigenic Therapeutics, Ipsen, Twist Bioscience Corporation, F. Hoffmann-La Roche Ltd., AstraZeneca PLC, GenScript Biotech Corporation, Exact Sciences Corporation, FOXO Technologies Inc., Watchmaker Genomics, Inc., Chroma Medicine, Inc., Cambridge Epigenetix Ltd., Bristol-Myers Squibb Company, EpiCypher, Inc., Omega Therapeutics, Inc., Promega Corporation, Bioneer Corporation, PerkinElmer, Inc., Gilead Sciences, Inc., Eurofins Scientific SE, ProteoGenix SAS, Abcam PLC, BioCat GmbH by AddLife AB, Creative Diagnostics, EpiGentek Group Inc., Lonza Group Ltd., Zenith Epigenetics Ltd., Agilent Technologies, Inc., BPS Bioscience, Inc., Fios Genomics Ltd., Creative Biogene, Sound Agriculture Company, Takara Holdings Inc., Illumina, Inc., Elysium Health, Inc., Pacific Biosciences of California, Inc, Cusabio Technology LLC, Zymo Research Corporation, Bayer AG, Bio-Rad Laboratories, Inc., and MorphoSys AG.

Market Segmentation & Coverage

This research report categorizes the Epigenetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Enzymes, Instruments & Accessories, Reagents & Kits, Service, and Software. The Enzymes is further studied across DNA-Modifying Enzymes and Protein-Modifying Enzymes. The Reagents & Kits is further studied across 5-hmC & 5-mC Analysis Kit, Antibodies, Bisulfite Conversion Kits, ChiP-seq Kits, Histones, and Whole Genome Amplification Kits.
  • Based on Technique, market is studied across Mass Spectrometry, Next-Generation Sequencing, Polymerase Chain Reaction & quantitative Polymerase Chain Reaction, and Sonication.
  • Based on Methods, market is studied across DNA Methylation and Histone Modifications.
  • Based on Application, market is studied across Cardiovascular Diseases, Developmental Biology, Immunology, Metabolic Diseases, and Oncology.
  • Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant growth in the prevalence of chronic and genetic disorders worldwide
      • 5.1.1.2. Favorable governmental initiatives and investments in drug discovery and development
      • 5.1.1.3. Growing inclination toward personalized medicines
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of epigenetics technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities for the advancement of epigenetics
      • 5.1.3.2. Expanding the application of epigenetics in non-oncology fields
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and limited application of epigenetics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing usage of reagents & kits for epigenetic research
    • 5.2.2. Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling
    • 5.2.3. Methods: Rising utilization of DNA methylation for X-chromosome inactivation
    • 5.2.4. Application: Increasing application of epigenetic tools in oncology
    • 5.2.5. End-User: Growing need for epigenetic tools from academic & research institutes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Epigenetics Market, by Product

  • 6.1. Introduction
  • 6.2. Enzymes
    • 6.2.1. DNA-Modifying Enzymes
    • 6.2.2. Protein-Modifying Enzymes
  • 6.3. Instruments & Accessories
  • 6.4. Reagents & Kits
    • 6.4.1. 5-hmC & 5-mC Analysis Kit
    • 6.4.2. Antibodies
    • 6.4.3. Bisulfite Conversion Kits
    • 6.4.4. ChiP-seq Kits
    • 6.4.5. Histones
    • 6.4.6. Whole Genome Amplification Kits
  • 6.5. Service
  • 6.6. Software

7. Epigenetics Market, by Technique

  • 7.1. Introduction
  • 7.2. Mass Spectrometry
  • 7.3. Next-Generation Sequencing
  • 7.4. Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
  • 7.5. Sonication

8. Epigenetics Market, by Methods

  • 8.1. Introduction
  • 8.2. DNA Methylation
  • 8.3. Histone Modifications

9. Epigenetics Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Developmental Biology
  • 9.4. Immunology
  • 9.5. Metabolic Diseases
  • 9.6. Oncology

10. Epigenetics Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Epigenetics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Epigenetics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Epigenetics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Zenith and Cencora Partner to Expedite ZEN-3694 Programme
    • 14.3.2. FOXO, DataRobot Partner for AI-Based Epigenetic Biomarker Research
    • 14.3.3. Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry
    • 14.3.4. MSU biochemist Receives USD 2.8 million NIH Grant For Epigenetic Research on Autism Spectrum Disorder
    • 14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
    • 14.3.6. AstraZeneca Advances its Pipeline and Highlights Progress in Immuno-Oncology, ADCs, Cell Therapy and Epigenetics At AACR
    • 14.3.7. Biomodal Releases Genetics And Epigenetics Solution
    • 14.3.8. Chroma Medicine Raises Stakes in Epigenetic Editing
    • 14.3.9. Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
    • 14.3.10. Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials

Companies Mentioned

  • 1. Diagenode S.A. by Hologic, Inc.
  • 2. STORM Therapeutics LTD
  • 3. Qiagen N.V.
  • 4. Integrated DNA Technologies, Inc. by Danaher Corporation
  • 5. Active Motif, Inc.
  • 6. Merck KGaA
  • 7. Novogene Co, Ltd.
  • 8. GenomeScan
  • 9. Thermo Fisher Scientific Inc.
  • 10. Abnova Corporation
  • 11. New England Biolabs, Inc.
  • 12. Epigenic Therapeutics
  • 13. Ipsen
  • 14. Twist Bioscience Corporation
  • 15. F. Hoffmann-La Roche Ltd.
  • 16. AstraZeneca PLC
  • 17. GenScript Biotech Corporation
  • 18. Exact Sciences Corporation
  • 19. FOXO Technologies Inc.
  • 20. Watchmaker Genomics, Inc.
  • 21. Chroma Medicine, Inc.
  • 22. Cambridge Epigenetix Ltd.
  • 23. Bristol-Myers Squibb Company
  • 24. EpiCypher, Inc.
  • 25. Omega Therapeutics, Inc.
  • 26. Promega Corporation
  • 27. Bioneer Corporation
  • 28. PerkinElmer, Inc.
  • 29. Gilead Sciences, Inc.
  • 30. Eurofins Scientific SE
  • 31. ProteoGenix SAS
  • 32. Abcam PLC
  • 33. BioCat GmbH by AddLife AB
  • 34. Creative Diagnostics
  • 35. EpiGentek Group Inc.
  • 36. Lonza Group Ltd.
  • 37. Zenith Epigenetics Ltd.
  • 38. Agilent Technologies, Inc.
  • 39. BPS Bioscience, Inc.
  • 40. Fios Genomics Ltd.
  • 41. Creative Biogene
  • 42. Sound Agriculture Company
  • 43. Takara Holdings Inc.
  • 44. Illumina, Inc.
  • 45. Elysium Health, Inc.
  • 46. Pacific Biosciences of California, Inc
  • 47. Cusabio Technology LLC
  • 48. Zymo Research Corporation
  • 49. Bayer AG
  • 50. Bio-Rad Laboratories, Inc.
  • 51. MorphoSys AG

LIST OF FIGURES

  • FIGURE 1. EPIGENETICS MARKET RESEARCH PROCESS
  • FIGURE 2. EPIGENETICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPIGENETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EPIGENETICS MARKET DYNAMICS
  • TABLE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM EPIGENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 332. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 333. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023